Danny Hsu, MBBS, FRACP, FRCPA

Australia

Clinical and laboratory haematologist
Haematology department, Liverpool Hospital
Australia

Danny Hsu is a consultant clinical and laboratory haematologist whom completed his medical degree at Monash University in Australia.  After his basic physician training in Melbourne, he permanently relocated to Sydney and became a Fellow of the Royal Australasian College of Physicians and The Royal College of Pathologist Australasia after completing training in clinical and laboratory haematology at St. George Hospital and Royal Prince Alfred Hospital.

Since 2011, Hsu has been a staff specialist at Liverpool Hospital where he is the current Director of Therapeutic Apheresis and Clinical Lead of Immune Haematology. He has extensive experience in the management of malignant and general hematological conditions, with a particular interest in rare diseases.  Due to his clinical and research expertise, Hsu has been a member of various international and national pharmaceutical industry advisory boards for rare hematological diseases (i.e. paroxysmal nocturnal hemoglobinuria, atypical hemolytic uraemic syndrome, immune thrombocytopenic purpura and thrombotic microangiopathies). He is also a current sitting council member of the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ).

Hsu remains active in clinical research and is also passionate about education.  He is a Conjoint Lecturer at the University of NSW and actively participates in mentoring, as well as lecturing for the School of Medicine.  He is also the co-founder of “Young Blood, a volunteer organization which assists in clinical teaching for hematology trainees, as well as to facilitate networking amongst the next generation of hematologists.